Literature DB >> 11179624

Use of the K-distribution for classification of breast masses.

P M Shankar1, V A Dumane, J M Reid, V Genis, F Forsberg, C W Piccoli, B B Goldberg.   

Abstract

The K-distribution had been introduced as a valid model to represent the statistics of the envelope of the backscattered echo from phantom and tissue. This paper investigates the efficacy of the parameters of this statistical model; namely, the effective number and the effective cross-section, to characterize breast lesions as benign or malignant. Based on the normalized values of the effective number and the effective scattering cross-section, images containing benign and malignant masses were classified for a data set from 52 patients having breast masses/lesions. The receiver operating characteristic (ROC) curves were then obtained to test the classification based on these two parameters. The results indicate that the parameters of the K-distribution may be useful in classification of the breast lesions as benign and malignant.

Entities:  

Mesh:

Year:  2000        PMID: 11179624     DOI: 10.1016/s0301-5629(00)00312-4

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  3 in total

1.  Role of ultrasound in the detection of apoptosis.

Authors:  Gregory J Czarnota
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-05       Impact factor: 9.236

2.  Three-dimensional high-frequency backscatter and envelope quantification of cancerous human lymph nodes.

Authors:  Jonathan Mamou; Alain Coron; Michael L Oelze; Emi Saegusa-Beecroft; Masaki Hata; Paul Lee; Junji Machi; Eugene Yanagihara; Pascal Laugier; Ernest J Feleppa
Journal:  Ultrasound Med Biol       Date:  2011-03       Impact factor: 2.998

3.  Assessment of Homodyned K Distribution Modeling Ultrasonic Speckles from Scatterers with Varying Spatial Organizations.

Authors:  Xiao Hu; Yufeng Zhang; Li Deng; Guanghui Cai; Qinghui Zhang; Yi Zhou; Kexin Zhang; Junhua Zhang
Journal:  J Healthc Eng       Date:  2017-09-05       Impact factor: 2.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.